Tuesday, October 2, 2018

These Cholesterol-Reducers May Save Lives. So Why Aren’t Heart Patients Getting Them? by GINA KOLATA


By GINA KOLATA

Powerful PCSK9 inhibitors were supposed to revolutionize care for cardiac patients. But insurers and other payers balked at sky-high prices.

Published: October 1, 2018 at 08:00PM

from NYT Health https://ift.tt/2DOZiTD
via IFTTT



from WordPress https://ift.tt/2xReNEP
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)